Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| TGFβRI-IN-3 | C28H23N3O2S | 2763602-67-9 | Details |
| LSN3318839 | C26H23Cl2N3O2 | 2764704-18-7 | Details |
| RSS0680 | C52H64N10O6S3 | 2769753-48-0 | Details |
| 306-N16B | C75H151N7O4S8 | 2803699-70-7 | Details |
| Aldometanib | C27H43Cl2N2.I | 2904601-67-6 | Details |
| NS2B/NS3-IN-3 | C19H21N3O2 | 2832876-90-9 | Details |
| LSD1-IN-27 | C24H25N3 | 2904571-94-2 | Details |
| Tubulin polymerization-IN-43 | C17H13F4N3O | 2773345-90-5 | Details |
| LTGO-33 | C21H17F4N3O3S | 2834106-06-6 | Details |
| BLU-222 | C15H17F2N7O2 | 2888704-84-3 | Details |
| Isatin-β-thiosemicarbazone | C9H8N4OS | 27830-79-1 | Details |
| (R)-CSN5i-3 | C28H29F2N5O2 | 2863607-74-1 | Details |
| Nicomol | C34H32N4O9 | 27959-26-8 | Details |
| AZD5462 | C30H41FN2O6 | 2787501-83-9 | Details |
| NLRP3-IN-11 | C17H17ClN4O2 | 2769040-91-5 | Details |
| RSH-7 | C22H25FN8O | 2764609-97-2 | Details |
| Semax acetate(80714-61-0 free base) | C37H51N9O10S.C2H4O2 | 2828433-33-4 | Details |
| PHGDH-IN-3 | C24H18FN3O4S2 | 2893778-31-7 | Details |
| Survodutide | 2805997-46-8 | Details |
| HIV-1 inhibitor-54 | C27H30N6O4S | 2771211-71-1 | Details |
| UC-764864 | C19H18N2OS | 278806-03-4 | Details |
| NP10679 | C23H26F3N3O3 | 2914889-88-4 | Details |
| MMP-7-IN-2 | C28H40ClF3N6O9S | 2848717-49-5 | Details |
| YPX-C-05 | C21H19N3O4 | 2894823-79-9 | Details |
| Zharp2-1 | C19H18N3O2PS | 2772600-18-5 | Details |
| TGFβ1-IN-3 | 2883813-58-7 | Details |
| Cepharanoline | C36H36N2O6 | 27686-34-6 | Details |
| PARP1-IN-5 dihydrochloride | C25H25ClN2O5S | 2823308-89-8 | Details |
| N-(5-(8-Amino-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-2-methylphenyl)methanesulfonamide hydrochloride | C14H17ClN6O2S | 2803477-07-6 | Details |
| SOS1-IN-15 | C28H27F3N6O2 | 2793404-47-2 | Details |
| PROTAC-O4I2 | C29H29ClN6O5S | 2785323-62-6 | Details |
| Tubulin polymerization-IN-47 | C22H21N3O3 | 2834087-62-4 | Details |
| Nrf2 activator-3 | C23H18F3N3O2 | 2766570-23-2 | Details |
| D4R agonist-1 | 2826198-44-9 | Details |
| PARP-2-IN-3 | 2915650-86-9 | Details |
| Siplizumab | 288392-69-8 | Details |
| (Rac)-AMXT-1501 4HCl | C??H??Cl?N?O? | 2771343-93-0 | Details |
| CYN 154806 TFA | C58H69F3N12O16S2 | 2828432-46-6 | Details |
| Vapitadine dihydrochloride | C17H20N4O.2ClH | 279253-83-7 | Details |
| 5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole | 2863687-18-5 | Details |
| MAO-B-IN-17 | C17H17F2NO2 | 2890188-81-3 | Details |
| Mtb-IN-2 | C17H12N2O4 | 2861190-30-7 | Details |
| Anti-inflammatory agent 51 | C22H22N6O6S | 2911610-03-0 | Details |
| VEGFR2-IN-1 | C22H18N6S | 2765224-55-1 | Details |
| A09-003 | 2911646-14-3 | Details |
| PPI-1019 | C36H54N6O5 | 290828-45-4 | Details |
| Atg4B-IN-2 | C21H30O3 | 2765008-88-4 | Details |
| GPR84 antagonist 3 | C29H27N5O | 2815263-05-7 | Details |
| p53 Activator 7 | C27H32F3N4OP | 2849340-59-4 | Details |
| DATPT | C24H38N6O3.ClH | 2891582-75-3 | Details |
| EX-A7140 | C56H94N12O28 | 2828433-41-4 | Details |
| SPEN-IN-1 | C27H20N4O | 2863686-82-0 | Details |
| Akt3 degrader 1 | C53H72N8O4 | 2836342-69-7 | Details |
| α-Glucosidase-IN-22 | C14H11N3O2S | 2870693-28-8 | Details |
| (R)-STU104 | C18H18O4 | 2767124-77-4 | Details |
| BI3231 | C16H14F2N4O3S | 2894848-07-6 | Details |
| GSK778 hydrochloride | 2863657-79-6 | Details |
| BTK-IN-16 | 2883232-92-4 | Details |
| PI5P4Ks-IN-2 | 2766854-03-7 | Details |
| COX-2-IN-34 | 2788578-71-0 | Details |
| Argininamide | C6H15N5O | 2788-83-2 | Details |
| PDL-1 cpd 10 | C21H23N5O2 | 2767424-13-3 | Details |
| CB1/2 agonist 3 | C25H41NO2 | 2772655-86-2 | Details |
| EIF2α activator 1 | C25H19F6N3O3 | 2851820-52-3 | Details |
| KWCN-41 | C18H17N3O2 | 2913223-17-1 | Details |
| SARS-CoV-2-IN-39 | C14H8ClF4NO3 | 2882823-03-0 | Details |
| Masoprocol | C18H22O4 | 27686-84-6 | Details |
| RI-962 | C28H28N6O2 | 2763831-53-2 | Details |
| Carboxylesterase-IN-3 | C11H6Cl2N4OS | 2764748-92-5 | Details |
| Aβ-IN-1 | 2766509-32-2 | Details |
| BE1218 | C30H30FNO4S2 | 2893967-40-1 | Details |
| Enpp/Carbonicanhydrase-IN-2 | C23H24FNO4S | 2883495-39-2 | Details |
| MyD88-IN-1 | C23H24N6O7S | 2911609-80-6 | Details |
| MC4033 | C16H13N3O3 | 28532-21-0 | Details |
| BLU0588 | C26H25N5O | 2810747-78-3 | Details |
| PG-116800 | C24H27N3O7S | 291533-11-4 | Details |
| Z26395438 | C17H15FN2O | 2803-63-6 | Details |
| ALPK1-IN-2 | C20H18F2N4O2S | 2765633-68-7 | Details |
| ALR2-IN-1 | C16H17N3O2S | 2799695-54-6 | Details |
| Alalevonadifloxacin | C22H26FN3O5.CH4O3S | 2892364-59-7 | Details |
| (S, R)-LSN 3318839 | C26H23Cl2N3O2 | 2765539-92-0 | Details |
| (Iso)-Fosdevirine | C20H17ClN3O3P | 2869918-45-4 | Details |
| SARS-CoV-2-IN-38 | 2882823-27-8 | Details |
| Lerdelimumab | 285985-06-0 | Details |
| SARS-CoV-2 3CLpro-IN-2 | C21H18F5N5O4 | 2765088-93-3 | Details |
| SARS-CoV-2 Mpro-IN-2 | C22H20Cl2N4O2S | 2768834-39-3 | Details |
| ALOX15-IN-2 | C23H29N3O4S | 2764818-23-5 | Details |
| MMP2-IN-1 | C15H13NO5S | 2764598-01-6 | Details |
| Carboxylesterase-IN-2 | C13H12N4OS | 2764748-88-9 | Details |
| hCAII-IN-9 | C15H16ClN3O5S2 | 2878477-18-8 | Details |
| DHFR-IN-4 | C18H21N5O2S | 2820126-49-4 | Details |
| PRMT6-IN-3 | C19H26N4O2S | 2890765-10-1 | Details |
| BPDA2 | 2907659-86-1 | Details |
| STX-478 | C16H12F5N5O2 | 2883540-92-7 | Details |
| PI3Kδ-IN-16 | C22H26N6O2 | 2766437-35-6 | Details |
| JPD447 | C20H23FN4 | 2883235-86-5 | Details |
| Estrogen receptor antagonist 8 | 2889370-92-5 | Details |
| Phosphatase-IN-1 | 2889356-55-0 | Details |
| Biotin-PEG3-SS-azide | C27H48N8O7S3 | 2866429-93-6 | Details |
| Lofendazam | C15H13ClN2O | 29176-29-2 | Details |
| Product Total： Product Page： | ||||
| 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||